Pureos Partners AG is a venture capital investor that invests in private companies developing innovative therapeutics, with an emphasis on next‑generation biologics and drug formats. The website also states that Pureos Partners AG holds a FINMA licence as a portfolio manager.
AI-generated
Offering
Products & services
Industry:Private Equity & Venture Capital
✓ Offered3
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Venture capital in private innovative drug development companies, focused on next-generation biological drugs and drug formats for severe diseases.
Portfolio investments in biotech companies
Investments in clinical and preclinical biotech companies in oncology, fibrosis, ophthalmology, immunology, neurology, infectious diseases and rare diseases.
Support for biotech start-ups and growth financing
Financing for seed, Series A, Series B, Series C and later development stages, including support with company build-up and clinical development.